Luisa Lemos

Choroideremia Research Foundation Announces Six New Global Grants to Accelerate Vision Science #CureCHM #VisionResearch #CRF einpresswire.com/article/819471…

Assinalar este dia é zelar pela equidade nas oportunidades, nos cuidados de saúde e no acesso a diagnóstico e terapia para as pessoas que vivem com doença rara. “Muito mais do que pode imaginar” é o tema de 2025. #Saúde #SNS #DoençasRaras

Excited to share our latest research on isogenic stem cell models for Choroideremia, featured on the cover of Stem Cells and Development! 🌱🧬 Discover their potential for studying RPE degeneration mechanisms. Read the full paper: doi.org/10.1089/scd.20… #ChoroideremiaResearch

Today we started with Scientific Session I: New therapeutic approaches involving #NRF2 with A.T. Dinkova-Kostova, A. Grochot-Przeczek, M. Seabra, I. Varela @IIBmCSICUAM D. Miljkovic, A. Čipak Gašparović and V. Marisa Costa

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

France #Choroideremia symposium. Thank you to all the brilliant minds from all over the world discussing CHM. Taking another step forward 🙏🏻🙏🏻@sharmaruchi29 @JKJolly4 @Vision_INM @elfridedebaere @MaliaEdwardsLab @MariyaMoosajee @MiguelSeabra6 @eyeMacLaren @rharbottle @mluisosca

Happy to present our last research work on Ocular Gene Therapy at #ARVO2024, Seattle, WA! @MSeabraLab Thanks to @ChampalimaudF @curechm for their funding support. #Choroideremia #Inheritedretinaldiseases

International #Choroideremia research network #ICRN breakfast. Fantastic early morning meeting, scientific presentation, brilliant researchers from across the globe #CureCHM #TeamCHM

ONLINE NOW: Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases dlvr.it/SzgyVm

Amazing poster discussion at #ESGCT2023 - annual meeting, in Brussels.

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

Our paper is now available at bioRxiv!

Happy to be part of the first CorEuStem Symposium on Standardizing Stem Cell Core Facilites in Europe, held at Champalimaud Foundation. Congratulations to the organization for these two great days of discussion. @CorEuStem @ChampalimaudF @COSTprogramme @MSeabraLab

Throssell-Hillier #Choroidermia award winners announced! Congratulations to Dr.Miguel Seabra Dr.Pedro Antas, Portugal: CRISPR-Based Gene Editing for CHM. ⁦@MiguelSeabra6⁩ ⁦@MSeabraLab⁩ einpresswire.com/article/623817…

.@TenreiroSandra da @nova_medschool está a desenvolver modelos de retina em laboratório que podem ser usados para estudar os mecanismos moleculares que levam ao desenvolvimento da retinopatia diabética. buff.ly/3Js6Efw #90SegundosCiência

Tomorrow on #RareDiseaseDay- Prof. Mariya Moosajee will be presenting @TheCrick on #Choroideremia. Thank you @MariyaMoosajee for lighting up for rare on this day and all year long🙏🏻🌸

Using mRNA, researchers have developed a promising approach for the intracellular delivery of genes in the eye, which may have the potential to prevent vision loss for inherited retinal diseases. Learn more in this week’s issue of Science Advances: scim.ag/181

Happy to share my first contribution at @TenreiroSandra Lab and @MSeabraLab Age-Related Changes of the Synucleins Profile in the Mouse Retina mdpi.com/2073100 #mdpibiomolecules a través de @Biomol_MDPI

1/2 Congratulations to @ChampalimaudF's Pedro Antas & Miguel Seabra for winning the Throssell Hillier Families Research Award for their project proposal “#CRISPR Based Gene Editing for #Choroideremia”👏👏 @curechm @CRFCanada Photography credits: © João Balsa